Ablation Therapy for Locally Advanced Pancreatic Cancer: Ongoing Trials and Perspectives

This talk was presented by Kevin El-Hayek, MD during the “Biology Meets Technique: to Operate or Not to Operate in Pancreatic Cancer” session at the SAGES 2021 Annual Meeting on September 3, 2021

[@khaliddurrani6432]

Seems there is no difference in the OS amongst various local ablative therapies. However IRE has an added advantage of sparing the encased vessels intact.